Overview

Dr. Scott Chambers is the chair of the Firm’s Intellectual Property Department and advises clients on complex intellectual property matters, focusing on utilizing the courts and government agencies, such as the U.S. Patent and Trademark Office (USPTO), to protect or defend clients’ rights.

Dr. Chambers helps clients avoid and resolve problems associated with protecting intellectual property, including litigation at the appellate and district court levels, and before the International Trade Commission. In addition to advising clients in patent infringement and validity issues, Dr. Chambers provides oversight for companies on mergers and acquisitions, trade secret and antitrust litigation. Dr. Chambers has represented companies before the USPTO, arguing their positions regarding patent prosecution and patent term extensions. As an expert witness, Dr. Chambers regularly provides testimony on U.S. patent law and procedure.

Previously, Dr. Chambers served as an associate solicitor for the USPTO, where he defended the USPTO’s patentability determinations and statutory interpretation before the U.S. Court of Appeals for the Federal Circuit and district court. He has also drafted Examination Guidelines for the Examining Corps of the USPTO and congressional testimony for the agency regarding biotechnology and patents. Highly recognized and honored for his work in the field of patents, Dr. Chambers has served as a frequent speaker on behalf of the USPTO at industry events involving the American Bar Association, the American Intellectual Property Law Association, the Intellectual Property Owners Association and the Biotechnology Industry Organization. He is also an adjunct faculty member at Georgetown University Law School, Catholic University Law School and George Washington Law School, where he teaches classes on international intellectual property law and advanced courses in patent law.

• Benitec Australia Ltd. V. Nucleonics, Inc., 495 F.3d 1340 (Fed. Cir. 2007)
• Abbott Laboratories v. Novapharm, Ltd., 323 F.3d 1324 (Fed. Cir. 2003)
• Emergency Fuel, LLC v. Pennzoil-Quaker State Co., 71 Fed. Appx. 826 (Fed. Cir. 2003)
• In re Dance, 160 F.3d 1339 (Fed. Cir. 1998)
• In re Clement, 131 F.3d 1464 (Fed. Cir. 1997)
• In re Emert, 124 F.3d 1458 (Fed. Cir. 1997)
• Hoechst-Roussel Pharmaceuticals, Inc. v. Lehman, 109 F.3d 756 (Fed. Cir. 1997)
• In re Mayne, 104 F.3d 1339 (Fed. Cir. 1997)
• Merck & Co., Inc. v. Kessler, 80 F.3d 1543 (Fed. Cir. 1996)
• In re Alton, 76 F.3d 1168 (Fed. Cir. 1996)
• Honigsbaum v. Lehman, 903 F. Supp. 8 (D.D.C. 1995)